Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$890K Sell
12,583
-1,207
-9% -$90.4K 0.04% 334
2025
Q4
$1.09M Buy
13,790
+2,249
+19% +$178K 0.05% 271
2025
Q3
$951K Buy
11,541
+1,384
+14% +$109K 0.05% 273
2025
Q2
$817K Buy
10,157
+527
+5% +$40.7K 0.05% 250
2025
Q1
$773K Sell
9,630
-809
-8% -$67.3K 0.06% 228
2024
Q4
$855K Buy
10,439
+1,062
+11% +$88.4K 0.08% 181
2024
Q3
$773K Buy
9,377
+59
+0.6% +$4.41K 0.07% 207
2024
Q2
$654K Buy
9,318
+194
+2% +$13.9K 0.06% 217
2024
Q1
$676K Sell
9,124
-8,574
-48% -$598K 0.06% 216
2023
Q4
$1.17M Buy
17,698
+12,835
+264% +$803K 0.05% 233
2023
Q3
$306K Buy
+4,863
New +$303K 0.04% 269

Other funds holding MET

Syon Capital's MET Position: Q1 2026 in Review

Syon Capital reduced its MetLife (MET) stake by 8.8% in Q1 2026, selling an estimated $90.4K and leaving 12,583 shares worth $890K. The position accounts for 0.04% of the portfolio, ranked #334.

Syon Capital first reported a position in MET in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.17M in Q4 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Syon Capital held 12,583 shares of MetLife worth $890K as of Q1 2026.
  • Syon Capital sold 1,207 MetLife shares in Q1 2026, an estimated $90.4K.
  • MetLife made up 0.04% of Syon Capital's portfolio in Q1 2026, its #334 holding.
  • Syon Capital first reported a position in MetLife in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's MetLife position peaked at $1.17M in Q4 2023.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.